Bioceres, an Argentinian developer of crop productivity traits for genetically modified seeds, withdrew its plans for an initial public offering on Wednesday. It originally filed in September 2015 with a proposed deal size of $81 million.
The Rosario, Argentina-based company was founded in 2002 and booked $11 million in sales for the 12 months ended June 30, 2015. It had planned to list on the NYSE under the symbol BIOX. Piper Jaffray and Itau BBA were set to be the joint bookrunners on the deal.
